~~<i id='BFDCBB9816'><strike id='BFDCBB9816'><tt id='BFDCBB9816'><pre id='BFDCBB9816'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

explore

author：explore 2025-09-30 18:00:19 - browse：8

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Mitch McConnell episode has important public health takeaway

explore

knowledge

explore

hotspot

focus

knowledge

MollyFergusonforSTATWhenMs.NcametoDr.JohnHogan’sofficelastAugust,ithadbeennearlythreemonthssincesheh

WSS

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Parkland mass shooting to be reenacted for lawsuit

Adults seen as increasingly susceptible to measles

Micronoma's microbiome cancer diagnostic approach under fire

No plane should take off without an EpiPen onboard

knowledge

explore

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

'Cuddling' is just what the doctor ordered for a 200

Dobbs anniversary: the lost opportunity of abortion as health care

‘Oppenheimer’ and the risks of AI in health care

Peter Hotez and the public health issue of online harassment

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Moonlake's readout produced a cash windfall. Risks remain

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Wildfire smoke exposes gaps in outdoor worker protections

Rock icon Freddie Mercury pre

knowledge

Mega Millions pot grows to $1.25 billion after no winner

New company forms to vet health AI models, root out weaknesses

What to expect as Trump is arraigned on his Jan 6. indictment

Adults seen as increasingly susceptible to measles

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

explore

hotspot

focus

knowledge